| Current research therapeutic strategies for Alzheimer’s disease treatment J Folch, D Petrov, M Ettcheto, S Abad, E Sánchez-López, ML García, ... Neural plasticity 2016, 2016 | 319 | 2016 |
| Memantine for the treatment of dementia: a review on its current and future applications J Folch, O Busquets, M Ettcheto, E Sánchez-López, RD Castro-Torres, ... Journal of Alzheimer's Disease 62 (3), 1223-1240, 2018 | 223 | 2018 |
| Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: In vitro and in vivo characterization E Sánchez-López, M Ettcheto, MA Egea, M Espina, A Cano, AC Calpena, ... Journal of nanobiotechnology 16, 1-16, 2018 | 191 | 2018 |
| Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part II-Ocular drug-loaded lipid nanoparticles E Sánchez-López, M Espina, S Doktorovova, EB Souto, ML García European Journal of Pharmaceutics and Biopharmaceutics 110, 58-69, 2017 | 161 | 2017 |
| Current applications of nanoemulsions in cancer therapeutics E Sánchez-López, M Guerra, J Dias-Ferreira, A Lopez-Machado, ... Nanomaterials 9 (6), 821, 2019 | 156 | 2019 |
| Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—Review of classical and new compounds: Part-I R Vieira, SB Souto, E Sánchez-López, A López Machado, P Severino, ... Pharmaceuticals 12 (4), 152, 2019 | 146 | 2019 |
| Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents EB Souto, J Dias-Ferreira, A López-Machado, M Ettcheto, A Cano, ... Pharmaceutics 11 (9), 460, 2019 | 141 | 2019 |
| Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part I–Barriers and determining factors in ocular delivery E Sánchez-López, M Espina, S Doktorovova, EB Souto, ML García European Journal of Pharmaceutics and Biopharmaceutics 110, 70-75, 2017 | 127 | 2017 |
| PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen—In vitro, ex vivo and in vivo characterization E Sánchez-López, MA Egea, A Cano, M Espina, AC Calpena, M Ettcheto, ... Colloids and surfaces B: biointerfaces 145, 241-250, 2016 | 122 | 2016 |
| Cationic surfactants: Self-assembly, structure-activity correlation and their biological applications LY Zakharova, TN Pashirova, S Doktorovova, AR Fernandes, ... Internathional Journal of Molecular Sciences 20 (22), 5534, 2019 | 110 | 2019 |
| Memantine‐loaded PEGylated biodegradable nanoparticles for the treatment of glaucoma E Sánchez‐López, MA Egea, BM Davis, L Guo, M Espina, AM Silva, ... Small 14 (2), 1701808, 2018 | 90 | 2018 |
| Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy A Cano, M Ettcheto, M Espina, C Auladell, AC Calpena, J Folch, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (4), 1073-1085, 2018 | 71 | 2018 |
| New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9 E Sánchez-López, M Ettcheto, MA Egea, M Espina, AC Calpena, J Folch, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 1171-1182, 2017 | 70 | 2017 |
| Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—strategies for in vivo administration: part-II R Vieira, SB Souto, E Sánchez-López, A López Machado, P Severino, ... Journal of clinical medicine 8 (9), 1332, 2019 | 60 | 2019 |
| Trends in atopic dermatitis—from standard pharmacotherapy to novel drug delivery systems EB Souto, J Dias-Ferreira, J Oliveira, E Sanchez-Lopez, ... International journal of molecular sciences 20 (22), 5659, 2019 | 53 | 2019 |
| Soft cationic nanoparticles for drug delivery: Production and cytotoxicity of solid lipid nanoparticles (SLNs) AM Silva, C Martins-Gomes, TE Coutinho, JF Fangueiro, ... Applied Sciences 9 (20), 4438, 2019 | 53 | 2019 |
| Flavonoid-enriched plant-extract-loaded emulsion: a novel phytocosmetic sunscreen formulation with antioxidant properties LC Cefali, JA Ataide, AR Fernandes, IMO Sousa, FCS Gonçalves, ... Antioxidants 8 (10), 443, 2019 | 53 | 2019 |
| The implication of the brain insulin receptor in late onset Alzheimer’s disease dementia J Folch, M Ettcheto, O Busquets, E Sánchez-López, RD Castro-Torres, ... Pharmaceuticals 11 (1), 11, 2018 | 53 | 2018 |
| Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia M Ettcheto, J Olloquequi, E Sanchez-Lopez, O Busquets, A Cano, ... Frontiers in aging neuroscience 11, 344, 2020 | 52 | 2020 |
| The involvement of peripheral and brain insulin resistance in late onset Alzheimer’s dementia J Folch, J Olloquequi, M Ettcheto, O Busquets, E Sánchez-López, A Cano, ... Frontiers in aging neuroscience, 236, 2019 | 50 | 2019 |
